CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Tough-to-Treat hodgkin lymphoma
Disease control OngoingThis study tests a combination of two drugs, ibrutinib and nivolumab, in adults with classical Hodgkin lymphoma that has come back or not responded to prior therapy. The goal is to see if this combination can shrink or control the cancer. About 18 participants will receive both d…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New drug combo shows promise for advanced Hodgkin's lymphoma
Disease control OngoingThis study tests a new combination of the immunotherapy drug camrelizumab plus chemotherapy (AVD) as a first treatment for people with advanced classical Hodgkin's lymphoma. The goal is to see if this combo can make the cancer disappear completely. About 60 adults aged 18-75 who …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC